Risk of Infection from Application of Two Types of Pharmaceutical Creams

Mostafa Essam Eissa

Abstract


Introduction: Infection risk from the misuse of multi-dose medicinal products is a seriousproblem which affects final consumer health and may impact on thereputation of pharmaceutical companies adversely.

Objectives:The current study aimed to trace the most important contributing factors in the infection transfer through the application of two selected types of medicinal topical creamsfor the treatment of skin disease conditions.

Methods: One type of the product that was subjected to the present study is anti-psoriatic while the other is steroidal anti-inflammatory antimicrobial creams that were packed in Aluminum tubes with orifice diameter of 0.173 cm2, approximately. The simulation study – conducted on these topical creams - integrated preservative efficacy test (PET) with dose-response model of infection to demonstrate the probability of infection that could occur due to unintentional transmission of pathogenic bacteria to damaged or injured skin of the patient.

Results:The studied model showed that although both products possessed antimicrobial power activity against standard strain microorganisms, yet the critical factor is the hygienic control of hands and fingers during application of the cream on the affected area.

Conclusion:The medicinal products itself were little affected by microbial contamination when they were enclosed in their primary packaging materials as was observed by the in-use study. However, the most important part was that portion of the product that was transferred to the patient skin. From the simulation study, it was expected that the situation could be aggravated if the hyiegenic practice was underestimated by hospital staff. 


Keywords


multi-dose medicinal products; topical creams; simulation study; preservative efficacy test; dose-response model; simulation study

Full Text:

PDF

References


Ashour, M. S., Mansy, M. S., &Eissa, M. E. (2011). Microbiologicalenvironmental monitoring in pharmaceuticalfacility. Egypt Acad J Biolog Sci, 3(1), 63-74.

Clontz, L. (2009). Microbial limit and bioburden tests (1st ed.). Boca Raton: CRC Taylor & Francis.

Denyer, S. &Baird, R. (2007). Guide to microbiologicalcontrol in pharmaceuticals and medicaldevices (1st ed.). BocaRaton, Fla.: CRC Press.

Eissa, M. (2016). QuantitativeMicrobial Risk AssessmentofPharmaceuticalProducts. PDA JournalOfPharmaceutical Science And Technology. http://dx.doi.org/10.5731/pdajpst.2016.007047

Elder, D.P. &Crowley, P. (2012). AntimicrobialPreservatives Part One: Choosing a Preservative System. Americanpharmaceuticalreview.com. Retrieved 23 February 2017, fromhttp://www.americanpharmaceuticalreview.com/Featured-Articles/38886-Antimicrobial-Preservatives-Part-One-Choosing-a-Preservative-System/

Hazlett, L., Rosen, D., &Berk, R. (1978). MurineCorneal Response to Heat-InactivatedPseudomonasaeruginosa. OphthalmicResearch, 10(2), 73-81. http://dx.doi.org/10.1159/000264939

Kampf, G. &Kramer, A. (2004). Epidemiologic Background of Hand Hygiene and Evaluationofthe Most ImportantAgentsforScrubs and Rubs. ClinicalMicrobiologyReviews, 17(4), 863-893. http://dx.doi.org/10.1128/cmr.17.4.863-893.2004

Kowalski, W. (2012). HospitalAirborneInfectionControl CRC Press. BocaRaton.

Lawin-Brussel, C., Refojo, M., Leong, F., Hanninen, L., &Kenyon, K. (1993). EffectofPseudomonasaeruginosaConcentration in ExperimentalContactLens--RelatedMicrobial Keratitis. Cornea, 12(1), 10-18. http://dx.doi.org/10.1097/00003226-199301000-00003

Leggett, H., Cornwallis, C., &West, S. (2012). MechanismsofPathogenesis, Infective Dose and Virulence in HumanParasites. Plos Pathogens, 8(2), e1002512. http://dx.doi.org/10.1371/journal.ppat.1002512

Rose, J. & Haas, C. (1999). A risk assessment framework for the evaluation of skin infections and the potential impact of antibacterial soap washing. American Journal Of Infection Control, 27(6), S26-S33. http://dx.doi.org/10.1016/s0196-6553(99)70039-8

Todar, K. (2017). The Normal Bacterial Flora of Humans. Textbookofbacteriology.net. Retrieved 23 February 2017, from http://textbookofbacteriology.net/normalflora.html

United StatesPharmacopeia (2015a). Preservative challenge test chapter<51>. Thirty-eighthRevision, NationalFormulary, 33th ed. Rockville, MD: The United StatesPharmacopeialConvention Inc.

United StatesPharmacopeia (2015b). Microbiologicalexaminationof non-sterileproducts: microbialenumeration test<61>. Thirty-eighthRevision, NationalFormulary, 33th ed. Rockville, MD: The United StatesPharmacopeialConvention Inc.

United StatesPharmacopeia (2015c). Microbiologicalexaminationof non-sterileproducts: testsforspecifiedmicroorganisms<62>. Thirty-eighthRevision, NationalFormulary, 33th ed. Rockville, MD: The United StatesPharmacopeialConvention Inc.




DOI: http://dx.doi.org/10.12955/emhpj.v10i1.1120

Refbacks

  • There are currently no refbacks.


Print ISSN 1804-5804, Online ISSN 1804-9702

(c) 2017 Central Bohemia University